Alan Green talks to Venture Life Group (VLG) CEO Jerry Randall about the company’s interim results.
Jerry goes through the numbers and commercial developments for the period, before discussing post period-end developments, including an independent study at Cardiff University on the effects on Dentyl Dual Action mouthwash on patients affected by COVID-19.
Jerry explains the resilience and adaptability of the Venture Life business model in countering the challenge of the COVID lockdown, and highlights how the group’s strong cash position will fund any future acquisitions.